Zevra Therapeutics
Zevra Therapeutics
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA) | Combined D,L-2-hydroxyglutaric Aciduria | Enrolling by invitation | Phase 1 | 2026-06-08 | NCT07125066 | |
| Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD) | medium chain acyl-CoA dehydrogenase deficiency | Recruiting | Phase 2 | 2026-06-08 | NCT06773026 |